Patient-Reported Outcomes in Evaluating Lorecivivint (SM04690) for Moderate to Severe Knee Osteoarthritis (STRIDES-1)
Clinical trial NCT04385303 · COMPLETED
Trial details
- NCT number
- NCT04385303
- Sponsor
- Biosplice Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-26
- Primary completion
- 2021-09-08
- Enrollment
- 496
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.